neurocysticercosis enigmatic disease pubmed ncbi abstract neurocysticercosis ncc infection central nervous system cns caused metacestode larval form parasite taenia sp factors contribute endemic nature cysticercosis inflammatory process occurs tissue surrounding parasite and/or distal result mechanisms disproportionate number cysts discrepancy lead difficulty proper diagnosis people low endemic regions regions lack laboratory resources cns cysticerci basic forms isolated cysts cysticercus cellulosae=cc racemose cysts cysticercus racemosus=cr meningeal parenchymal ventricular mixed location clinical manifestations based fundamental syndromes occur isolation epilepsy intracranial hypertension asymptomatic symptomatic fatal acute sub-acute chronic picture remission exacerbated cerebrospinal fluid csf normal patients viable cysticerci patients begin exhibit classical syndrome ncc csf show routine analysed parameters computed tomography ct magnetic resonance imaging mri allowed non-invasive diagnoses lead false negatives treatment highly controversial issue characterised individualised therapy sessions drugs commonly praziquantel pzq albendazole abz choice anti-inflammatory drugs includes steroids dextrochlorpheniramine dcp hydrocephalus common secondary effect ncc surgical cases hydrocephalus submitted ventricle-peritoneal shunt vps immediately cysticidal treatment surgical extirpation cyst lead absence surrounding inflammatory process progression ncc simple complicated remission treatment exhibit symptoms disappear long periods time persist death unknown neglected controversial aspects ncc impaired fourth ventricle syndrome presence chronic brain oedema psychic complaints addition lack detectable glucose csf re-infection discussed 
